Hims launches new injectable and oral TRT for eligible U.S. men

Hims estimates 20 million U.S. men are affected by low testosterone. The company launched new injectable and oral testosterone replacement therapy (TRT) options for eligible men. Pete Stahl, MD & SVP of Men’s Health at Hims, provided the information regarding the new TRT options. Hims announced it will add new supplements to its men's health line in the next couple of months.

Hims is expanding access to testosterone replacement therapy through new injectable and oral options for eligible men in the U.S.

Source: @wearehims